|
[1]
|
Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006;368(9554):2211 − 8. http://dx.doi.org/10.1016/S0140-6736(06)69895-4CrossRef
|
|
[2]
|
Kile JC, Ren R, Liu L, Greene CM, Roguski C, Iuliano AD, et al. Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017. MMWR Morb Mortal Wkly Rep 2017;66(35):928 − 32. http://dx.doi.org/10.15585/mmwr.mm6635a2CrossRef
|
|
[3]
|
Cheng KF, Leung PC. What happened in China during the 1918 influenza pandemic?. Int J Infect Dis 2007;11(4):360 − 4. http://dx.doi.org/10.1016/j.ijid.2006.07.009CrossRef
|
|
[4]
|
Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 " Spanish” influenza pandemic. Bull Hist Med 2002;76(1):105 − 15. http://dx.doi.org/10.1353/bhm.2002.0022CrossRef
|
|
[5]
|
Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis 2006;12(1):9 − 14. http://dx.doi.org/10.3201/eid1201.051254CrossRef
|
|
[6]
|
Viboud C, Simonsen L, Fuentes R, Flores J, Miller MA, Chowell G. Global Mortality Impact of the 1957-1959 Influenza Pandemic. J Infect Dis 2016;213(5):738 − 45. http://dx.doi.org/10.1093/infdis/jiv534CrossRef
|
|
[7]
|
WHO. Pandemic Influenza Risk Management WHO Interim Guidance. 2013. [2018-2-19] http://www.who.int/influenza/preparedness/pandemic/GIP_PandemicInfluenzaRiskManagementInterimGuidance_Jun2013.pdf?ua=1. |
|
[8]
|
Chang WK. National influenza experience in Hong Kong, 1968. Bull World Health Organ 1969;41(3):349 − 51. |
|
[9]
|
Guo YJ, Liu LY, Dong ZY, Zhang SL, Shen GZ, Wang MH, et al. Influenza activity in human population in China since 1968. Chin J Exp Clin Virol 1993;7(3):237 − 41. (In Chinese). |
|
[10]
|
Chen H. H5N1 avian influenza in China. Sci China C Life Sci 2009;52(5):419 − 27. http://dx.doi.org/10.1007/s11427-009-0068-6CrossRef
|
|
[11]
|
Liang W, Feng L, Xu C, Xiang N, Zhang Y, Shu Y, et al. Response to the first wave of pandemic (H1N1) 2009: experiences and lessons learnt from China. Public Health 2012;126(5):427 − 36. http://dx.doi.org/10.1016/j.puhe.2012.02.008CrossRef
|
|
[12]
|
Yu H, Feng L, Viboud CG, Shay DK, Jiang Y, Zhou H, et al. Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China. Influenza Other Respir Viruses 2013;7(6):1350 − 60. http://dx.doi.org/10.1111/irv.12121CrossRef
|
|
[13]
|
Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 2012;12(9):687 − 95. http://dx.doi.org/10.1016/S1473-3099(12)70121-4CrossRef
|
|
[14]
|
Gao R, Cao B, Hu Y, Feng ZJ, Wang DY, Hu WF, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013;368(20):1888 − 97. http://dx.doi.org/10.1056/NEJMoa1304459CrossRef
|
|
[15]
|
Ke C, Mok CKP, Zhu W, Zhou H, He J, Guan W, et al. Human Infection with Highly Pathogenic Avian Influenza A(H7N9) Virus, China. Emerg Infect Dis 2017;23(8):1332 − 40. http://dx.doi.org/10.3201/eid2308.170600CrossRef
|
|
[16]
|
China. MoAoPsRo. Update on National H7N9 Surveillance among Poultry, January 2018. [2018-3-10]. http://www.syj.moa.gov.cn/dwybfk/201802/t20180228_6137566.htm. |
|
[17]
|
Yang J, Atkins KE, Feng L, Pang M, Zheng Y, Liu X, et al. Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine 2016;34(47):5724 − 35. http://dx.doi.org/10.1016/j.vaccine.2016.10.013CrossRef
|